Literature DB >> 13590248

[Prevention of allergic encephalomyelitis by prior injection of adjuvants].

M W KIES, E C ALVORD.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1958        PMID： 13590248     DOI： 10.1038/1821106a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  ANTIBODY STUDIES IN MULTIPLE SCLEROSIS AND EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS.

Authors:  E A CASPARY; E J FIELD; E J BALL
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-02       Impact factor: 10.154

2.  Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.

Authors:  Richard A O'Connor; Xujian Li; Seth Blumerman; Stephen M Anderton; Randolph J Noelle; Dyana K Dalton
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

3.  Depression of delayed hypersensitivity by pretreatment with Freund-type adjuvants. I. Description of the phenomenon.

Authors:  G L Asherson; G G Allwood
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

4.  Relationship between the incidence of experimental allergic encephalomyelitis and the development of adjuvant disease.

Authors:  N Allegretti; B Vitale
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

5.  Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1980-11       Impact factor: 4.307

6.  Shifts in the epitopes of myelin basic protein recognized by Lewis rat T cells before, during, and after the induction of experimental autoimmune encephalomyelitis.

Authors:  F Mor; I R Cohen
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized allogeneic lymphocytes.

Authors:  G A Hashim
Journal:  Neurochem Res       Date:  1981-06       Impact factor: 3.996

8.  Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs.

Authors:  G A Hashim
Journal:  Neurochem Res       Date:  1980-02       Impact factor: 3.996

9.  Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.

Authors:  JangEun Lee; Emily K Reinke; Alla L Zozulya; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

10.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.

Authors:  S Stosic-Grujicic; Z Ramic; V Bumbasirevic; L Harhaji; M Mostarica-Stojkovic
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.